Pharmaceutical company Merck will invest $1 billion to build a 470,000-square-foot facility in Wilmington, Delaware, in a bid to boost domestic production, the company said in an April 29 statement.
The facility, located at the Chestnut Run Innovation & Science Park, is expected to create “more than 500 full-time roles and roughly 4,000 construction jobs,” the company stated.
